已收盘 09-20 16:00:00 美东时间
-0.055
-0.16%
Viatris reports Q1 EPS in line with consensus at $0.67, with sales slightly missing expectations at $3.66 billion. Strong growth in Emerging Markets and Europe offset by challenges in North America. Guidance adjusted slightly downward for 2024.
05-10 02:23
格隆汇5月5日丨重药控股(000950.SZ)发布公告,公司下属控股子公司重庆医药(集团)股份有限公司(以下简称“重药股份”)近日收到国家药品监督管理局核准签发...
05-05 17:56
格隆汇8月26日丨恒瑞医药(600276.SH)公布,公司收到国家药品监督管理局下发的《受理通知书》,公司提交的SHR0302片药品上市许可申请,本品适用于非甾...
2023-08-26 14:54
Reports Total Revenues of $3.92 Billion; U.S. GAAP Net Earnings of $264 Million; Adjusted EBITDA of $1.31 Billion; U.S. GAAP Net Cash Provided by Operating Activities of $515 Million; and Fr...
2023-08-07 18:59